Indiana University Health Central Indiana Cancer Centers

Indianapolis, Indiana 46227

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Kidney Neoplasms

Studies at this site

• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) — Stopped early